ADHD

How can we help this unique patient population thrive? Experts weigh in at the 2022 APA Annual Meeting.

What are the unique challenges for individuals with ADHD?

At the 2022 Pediatric Academic Societies meeting, Shruti Mittal, MD, FAAP, looked at how many children with attention-deficit/hyperactivity disorder get started on behavioral therapy before medication in the preschool years.

At the 43rd National Conference on Pediatric Health Care for nurse practitioners in Dallas, Texas, a look at the newest medications for children with attention-deficit/hyperactivity disorder.

Catch up on all the latest in ADHD from the The American Professional Society of ADHD (attention-deficit/hyperactivity disorder) and Related Disorders (APSARD) virtual 2022 Annual Meeting.

In a clinical study of healthy adults, Dyanavel XR tablets were deemed to be bioequivalent to amphetamine extended-release oral suspension in patients with attention-deficit/hyperactivity disorder (ADHD) by the US Food and Drug Administration (FDA).

At the virtual 2021 American Academy of Pediatrics National Conference & Exhibition, Grace Wang, MD, FAAP, discusses how treatment of underlying sleep disorders can improve ADHD symptomatology.

A study has found that prenatal analgesic opioid exposure of 5 or more weeks is associated with a slightly elevated risk of attention-deficit/hyperactivity disorder (ADHD) in children compared to exposure of 4 weeks or less.

AZSTARYS (serdexmethylphenidate and dexmethylphenidate) is available for prescription to help provide rapid and extended duration of attention-deficit/hyperactivity disorder (ADHD) symptoms.

A study examines the effect of after-school activity participation on a child's attention-deficit/hyperactivity disorder (ADHD) severity.

Stimulants are recommended as the first-line treatment for attention-deficit/hyperactivity disorder (ADHD). A study examines whether α2-adrenergic agonists could be effective as well.

A study examines if promoting positive behaviors including masking leads to improved face covering in children with autism spectrum disorder and/or attention-deficit/hyperactivity disorder.

The US Food and Drug Administration (FDA) approves first novel non-stimulant medication to treat attention-deficit/hyperactivity disorder (ADHD) in children in a decade.

Unfortunately, disparities in health care are nothing unusual. A report examines if there are disparities in attention-deficit/hyperactivity disorder (ADHD) diagnosis and treatment due to race and ethnicity.

A new study examines whether maternal autoimmune diseases are linked to attention-deficit/hyperactivity disorder (ADHD).

A presentation at the virtual 2020 American Academy of Pediatrics National Conference & Exhibition reminded practitioners of the 3 guiding principles of psychopharmacology.

COVID-19 has created many stresses: mental, job-related, and health. For some caregivers, these stressors are complicated further with caring for a child with attention-deficit/hyperactive disorder (ADHD).

More than 1 condition can have an impact on health outcomes. A new investigation examines how multimorbidity can impact educational outcomes.

Attention-deficit/hyperactivity disorder (ADHD) was first recognized over 100 years ago, but the diagnostic criteria has changed over the years. Here's a look at the latest guidance for diagnosing ADHD.

Following the diagnosis of attention-deficit/hyperactivity disorder (ADHD), the next step is treatment, which can include parent behavior management training, school-based interventions, and medication. Here's a look at the latest in ADHD treatments.

Research has indicated that prenatal exposure to acetaminophen has an impact on attention-deficit/hyperactivity disorder (ADHD). An investigation offers even more evidence.

Attention-deficit/hyperactivity disorder (ADHD) is marked by age-inappropriate levels of inattention and activity. A report from Finland examines how relative immaturity in the first years of school could increase the risk of ADHD medication use.

Endocrine-disrupting chemicals are nearly ubiquitous in day-to-day life. Could they be linked to attention-deficit/hyperactivity disorder-like (ADHD) behavior?

Severe iodine deficiency in pregnancy has been linked to intellectual disabilities in offspring. An investigation studies whether the same is true for mild-to-moderate deficiency.

Tics and attention-deficit/hyperactivity disorder can co-occur. A presentation at the 2020 Virtual Conference on Pediatric Health Care offers guidance.